Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Masato Yonezawa

Masato Yonezawa

Active Motif, Inc. USA

Title: Novel technologies for analyzing epigenome of clinical cancer samples

Biography

Biography: Masato Yonezawa

Abstract

Large-scale cancer genome projects such as TCGA (The Cancer Genome Atlas) and ICGC (International Cancer Genome Consortium) revealed a great number of potential new therapeutic targets among epigenetic factors. This raises the needs for systematic analysis of Epigenomic profiles and epigenetic mechanisms of cancer. Active motif specializes in epigenetic research tools and has developed a series of omics tools to study cancer epigenomes. This study highlights mass spec techniques to identify more than 80 different post-translational modifications of histone proteins, ATAC-Seq, a method for genome-wide identification of open chromatin regions and ChIP-Seq, a method for mapping histone modifications and transcription factor binding sites across the genome. We optimized protocols for analyzing formaldehyde-fixed samples by ATAC-Seq as well as FFPE-preserved samples by ChIP-Seq. Our technologies facilitate the analysis of clinical samples that have been difficult to work with previously. We discuss how these tools can help our understanding of the mechanisms underlying cancer and give insights into diagnostics and cancer therapy.